PTC THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ptc Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q3 2024.
  • Ptc Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$107M, a 19.8% increase year-over-year.
  • Ptc Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$453M, a 29.4% increase year-over-year.
  • Ptc Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$627M, a 12.1% decline from 2022.
  • Ptc Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$559M, a 6.7% decline from 2021.
  • Ptc Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$524M, a 19.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$453M -$107M +$26.3M +19.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$480M -$99.2M +$99.7M +50.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$579M -$91.6M +$47.4M +34.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$627M -$156M +$15.1M +8.83% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$642M -$133M -$23.7M -21.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$618M -$199M -$46.8M -30.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$571M -$139M -$12.2M -9.65% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$559M -$171M -$27.6M -19.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$531M -$109M +$24.3M +18.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$556M -$152M -$33.7M -28.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$522M -$127M +$1.92M +1.49% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 -$524M -$143M -$68.9M -92.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$455M -$134M -$63.9M -91.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 -$391M -$118M +$63.1M +34.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$454M -$129M -$16M -14.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 -$438M -$74.4M +$3.32M +4.28% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$441M -$69.7M -$9.7M -16.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 -$432M -$181M -$140M -334% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 -$292M -$113M -$40.6M -56.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$252M -$77.7M -$29.3M -60.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$222M -$60M -$9.03M -17.7% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$213M -$41.8M -$32.3M -339% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$181M -$72.1M -$52.9M -274% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$128M -$48.3M -$49.6M -3906% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$78.5M -$51M -$17.2M -51.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$61.3M -$9.52M +$7.96M +45.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$69.2M -$19.3M +$9.79M +33.7% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$79M $1.27M +$28.1M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$107M -$33.7M +$1.43M +4.06% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$108M -$17.5M +$21.4M +55.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$130M -$29.1M +$12.2M +29.5% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$142M -$26.8M +$24.2M +47.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$166M -$35.2M +$8.06M +18.6% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-06
Q2 2016 -$174M -$38.9M -$553K -1.44% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-06
Q1 2016 -$174M -$41.2M -$3.32M -8.75% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-06
Q4 2015 -$170M -$50.9M -$23.7M -86.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$147M -$43.2M -$15.9M -58.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$131M -$38.4M -$13.3M -52.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$118M -$37.9M -$23.8M -169% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$93.8M -$27.3M -$9.38M -52.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$84.4M -$27.3M -$22.9M -518% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$61.5M -$25.1M -$10.5M -72.1% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$51M -$14.1M +$587K +4% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$51.6M -$17.9M -$11.6M -185% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-02
Q3 2013 -$40M -$4.42M +$2.88M +39.5% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-02
Q2 2013 -$42.8M -$14.6M -$8.52M -140% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-02
Q1 2013 -$34.3M -$14.7M -$8.09M -123% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-02
Q4 2012 -$26.2M -$6.27M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-06
Q3 2012 -$7.3M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-06
Q2 2012 -$6.07M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-06
Q1 2012 -$6.6M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.